1. Home
  2. ILAG vs LGVN Comparison

ILAG vs LGVN Comparison

Compare ILAG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILAG
  • LGVN
  • Stock Information
  • Founded
  • ILAG N/A
  • LGVN 2014
  • Country
  • ILAG Hong Kong
  • LGVN United States
  • Employees
  • ILAG N/A
  • LGVN N/A
  • Industry
  • ILAG Office Equipment/Supplies/Services
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • ILAG Consumer Discretionary
  • LGVN Health Care
  • Exchange
  • ILAG Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • ILAG 8.0M
  • LGVN 7.8M
  • IPO Year
  • ILAG 2022
  • LGVN 2021
  • Fundamental
  • Price
  • ILAG $0.59
  • LGVN $3.44
  • Analyst Decision
  • ILAG
  • LGVN Strong Buy
  • Analyst Count
  • ILAG 0
  • LGVN 1
  • Target Price
  • ILAG N/A
  • LGVN $12.00
  • AVG Volume (30 Days)
  • ILAG 344.8K
  • LGVN 14.9M
  • Earning Date
  • ILAG 07-23-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • ILAG N/A
  • LGVN N/A
  • EPS Growth
  • ILAG N/A
  • LGVN N/A
  • EPS
  • ILAG N/A
  • LGVN N/A
  • Revenue
  • ILAG $6,443,357.00
  • LGVN $978,000.00
  • Revenue This Year
  • ILAG N/A
  • LGVN $137.24
  • Revenue Next Year
  • ILAG N/A
  • LGVN $50.77
  • P/E Ratio
  • ILAG N/A
  • LGVN N/A
  • Revenue Growth
  • ILAG N/A
  • LGVN N/A
  • 52 Week Low
  • ILAG $0.33
  • LGVN $0.77
  • 52 Week High
  • ILAG $1.25
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • ILAG 54.45
  • LGVN 55.56
  • Support Level
  • ILAG N/A
  • LGVN N/A
  • Resistance Level
  • ILAG $0.58
  • LGVN $6.40
  • Average True Range (ATR)
  • ILAG 0.04
  • LGVN 0.52
  • MACD
  • ILAG -0.00
  • LGVN 0.06
  • Stochastic Oscillator
  • ILAG 92.00
  • LGVN 54.47

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: